Clinical Trials Directory

Trials / Conditions / Vaccine-Preventable Diseases

Vaccine-Preventable Diseases

32 registered clinical trials studyying Vaccine-Preventable Diseases7 currently recruiting.

StatusTrialSponsorPhase
RecruitingPlaying Game to Learn About Children's Vaccine Project
NCT05984849
Michigan State UniversityN/A
Not Yet RecruitingLong-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents
NCT07032610
Chiang Mai University
RecruitingImmunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After
NCT06978621
Chiang Mai UniversityPhase 3
CompletedSafety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previous
NCT06582277
OsivaxPhase 2
Active Not RecruitingImpact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the
NCT06633835
NovavaxPhase 4
RecruitingSafety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Health
NCT06569823
Dynavax Technologies CorporationPhase 1 / Phase 2
CompletedVaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey
NCT06872814
Fondazione IRCCS Policlinico San Matteo di Pavia
CompletedCulturally Tailored HPV Psychoeducational Multimedia Intervention
NCT06098690
University of Texas, El PasoN/A
CompletedImmunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adole
NCT06298708
Chiang Mai UniversityPhase 3
CompletedImproving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encount
NCT06074237
Corewell Health EastN/A
Active Not RecruitingGame-Based Intervention to Promote HPV Vaccination
NCT06162676
Michigan State UniversityN/A
CompletedStudy to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed b
NCT06541093
Uvax Bio LLCEARLY_Phase 1
Not Yet RecruitingAnimal Bite Victims Seeking Medical Services at Concerned Hospitals
NCT06054581
Assiut University
CompletedReducing COVID-19 Vaccine Hesitancy Among Hispanic Parents
NCT06036134
Arizona State UniversityN/A
CompletedThe Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection
NCT06065176
Sarang K. Yoon, DO, MOHPhase 4
CompletedBuilding Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
NCT06124131
Tulane UniversityN/A
CompletedImmune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®)
NCT06104345
Helsinki University Central HospitalPhase 4
RecruitingA Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
NCT06088745
Beijing Luzhu Biotechnology Co., Ltd.Phase 3
UnknownFine Needle aSpiration of Lymph nodEs to Study vAccine-induced Immunity
NCT06202703
Leiden University Medical CenterN/A
UnknownA Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
NCT05750017
Beijing Luzhu Biotechnology Co., Ltd.Phase 1
RecruitingSafety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Ab
NCT06137755
CHA Vaccine Institute Co., Ltd.Phase 1
Active Not RecruitingHerpes Virus Infections in Kidney Transplant Patients
NCT05604911
Susanne Dam Nielsen, MD, DMSc
CompletedTrial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF
NCT05506969
Dynavax Technologies CorporationPhase 2
CompletedEffectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Eld
NCT05283902
Federal University of Espirito Santo
UnknownSafety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-deto
NCT05193734
University Hospital, GenevaPhase 2 / Phase 3
CompletedTrial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-
NCT05245838
Dynavax Technologies CorporationPhase 1
UnknownHashtag HPV: HPV Vaccine Twitter Education Program
NCT05204030
University of Arkansas, FayettevilleN/A
CompletedA Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine
NCT06147895
CHA Vaccine Institute Co., Ltd.Phase 1
CompletedVolatility and Heterogeneity of Vaccine Sentiments Means Continuous Monitoring is Needed When Measuring Messag
NCT05499299
The University of Hong KongN/A
CompletedAn Evaluation of a Dynamic Web-Based Visualization of Community Immunity
NCT04787913
Laval UniversityN/A
UnknownPneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia
NCT05145101
Hannah Garcia Garrido
CompletedTesting the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125
University of California, Los AngelesN/A